ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals Inc (ALNY)

255,29
2,22
( 0,88% )
Mis à jour : 16:56:09
Quarter End Déc 2022Mar 2023Juin 2023Sept 2023Déc 2023Mar 2024Juin 2024Sept 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 335,04M319,29M318,75M750,53M439,72M494,33M659,83M500,92M
Revenu d'exploitation -188,61M-149,81M-229,83M213,87M-116,4M-43,44M48,61M-76,91M
Revenu avant impôt -207,02M-172,36M-274,21M150,74M-137,69M-63,59M-11,17M-108,66M
Revenu net -207,49M-174,1M-276,02M147,75M-137,87M-65,94M-16,89M-111,57M
Dividendes privilégiés 00000000
Résultat de base par action 00000000
EBIT -73,95M-153,32M-273,99M156,21M-136,76M-49,47M-15,6M-528,36M
EBITDA -174,3M-135,74M-216,65M227,2M-102,92M-29,92M63,62M-62,92M
Fin d'année 31 Décembre 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Revenu total 47,16M89,91M74,91M219,75M492,85M844,29M1,04B1,83B
Revenu d'exploitation -424,59M-500,09M-814,67M-939,43M-828,44M-708,65M-785,07M-282,18M
Revenu avant impôt -410,11M-490,87M-760,67M-885,25M-855,6M-852,14M-1,13B-433,52M
Revenu net -410,11M-490,87M-761,5M-886,12M-858,28M-852,82M-1,13B-440,24M
Dividendes privilégiés 00000000
Résultat de base par action -4.772-4.925-7.526-7.898-7.372-7.096-9.128-3.508
EBIT -418,42M-503,11M-789,94M-918,7M-782,91M-727,96M-791,28M-407,86M
EBITDA -414,99M-488,19M-801,87M-922,83M-798,24M-661,09M-740,6M-228,12M